SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid escalating US-Israel-Iran tensions, polarizing community sentiment between expectations of a significant market downturn and calls to 'buy the dip' based on historical geopolitical recoveries, alongside active debate over oil market stability and market manipulation.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Escalating Middle East tensions, following drone strikes on Saudi oil facilities and effective restrictions in the Strait of Hormuz, are sending crude prices soaring, leading the community to anticipate a significant short squeeze and parabolic rally for low-float energy play Indonesia Energy Corp.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is trending amidst surging oil prices driven by escalating Middle East tensions, including drone strikes on Saudi oil infrastructure and threats to the Strait of Hormuz. The community is heavily focused on potential short squeezes and the stock's low float, positioning it as a leading play in the volatile energy sector.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as escalating geopolitical tensions involving the US, Israel, and Iran spark intense community debate, with many divided between anticipating a significant market correction and a "buy the dip" mentality, while concerns over rising oil prices and market manipulation remain key talking points.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending due to escalating geopolitical tensions in the Middle East, with reports of US-Israeli strikes on Iran and retaliatory attacks leading to significant disruptions and increased war risk premiums for shipping through the critical Strait of Hormuz. The community is actively discussing the potential for a substantial oil price spike and the broader implications for global supply, overshadowing OPEC+'s modest output increase.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as escalating Middle East tensions threaten global LNG supply routes like the Strait of Hormuz, leading to anticipation of surging gas prices and a significant short squeeze. The community highlights VG's strong Q4 performance and rapidly expanding capacity, believing the company is exceptionally positioned to capitalize on current market dynamics despite conservative future guidance.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is experiencing a surge of interest after activist investor Elliott Management disclosed a substantial stake, advocating for governance and strategic overhauls to improve the company's lagging performance against rivals. The community is buzzing with optimism for a potential turnaround and a new CEO's impact, despite past frustrations and concerns over broader market conditions.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil (XOM) is trending as escalating geopolitical tensions in the Middle East, particularly around potential disruptions to oil flows through the Strait of Hormuz, are driving a significant surge in crude prices across global markets. The community is actively debating whether this reflects a sustainable surge for energy stocks, with many buying on expectations of higher oil prices, while others anticipate a temporary spike followed by a pullback.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending sharply lower after the FDA indicated its Phase I/II data for the Huntington's disease gene therapy, AMT-130, is currently insufficient for a BLA and recommended a Phase III trial. The community is expressing widespread frustration over the FDA's perceived 'moving goalposts' on accelerated approvals, with intense debate emerging on the asset's path forward and whether this signals a buying opportunity or further decline.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is rallying on an earnings beat and highly optimistic revenue guidance, fueled by surging demand for its 800G optical transceivers critical for AI data centers. The community is sharply divided, with bulls highlighting its essential role in AI infrastructure and aggressive growth outlook, while skeptics point to historical over-guidance and concerns over a recent stock offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference PR...

MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041

MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041 MetaVia Builds Comprehensive Global Patent Protection...

What Does the Market Think About MetaVia Inc?

MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option

MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering...

MetaVia Stock Slides After Pricing Public Offering

(RTTNews) - MetaVia Inc. (MTVA) shares traded at $3.4050, down 39.03% or $2.18 lower, after the company announced the pricing of an $8.1 million underwritten public offering...

MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering

MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering PR Newswire CAMBRIDGE, Mass., Jan. 15, 2026...

MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile

MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic...

MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference

MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference PR Newswire CAMBRIDGE, Mass., Dec. 29...

MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement

MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire CAMBRIDGE, Mass., Dec. 22, 2025 CAMBRIDGE, Mass...

<ul class="summary-bullets"><li>CIMG will implement a 20-for-1 reverse stock split, effective December 5.</li><li>MetaVia’s 1-for-11 reverse stock split of common stock will come into effect on December 4.</li><li>Treasure Global said its 1-for-20 reverse stock split of common stock will come into effect on December 5.</li></ul>&nbsp;Companies often use reverse stock splits to maintain their stock exchange listing, as major exchanges require the stock’s price to trade above $1. Falling below that level for 30 straight trading days triggers a deficiency notice, and the company is given a limited window to lift the share price.A reverse split raises the stock’s price by reducing the share count, helping the company regain compliance and avoid delisting.On Friday, four stocks will begin trading post a reverse split:CIMG Inc. (IMG), a digital health and sales development company, is set for a 20-for-1 reverse stock split, which takes effect on December 5. Post-split, CIMG’s stock will continue trading on Nasdaq under the symbol “IMG.” The reverse split will reduce the company’s outstanding shares to around 15.5 million from approximately 310 million.The reverse split also applies to stock options and warrants, with fractional shares rounded up to the nearest whole share.On Thursday, <a href="https://stocktwits.com/symbol/IMG">IMG stock</a> was down 10%, while retail sentiment on Stocktwits remained in the ‘bearish’ zone over the past 24 hours.MetaVia Inc. (MTVA), a clinical-stage biotech company focused on cardiometabolic diseases, announced a 1-for-11 reverse stock split of its common stock, effective December 4, post-market hours.Starting December 5, MetaVia’s shares will trade on Nasdaq on a split-adjusted basis under the symbol “MTVA.” The reverse split reduces outstanding shares from around 25.4 million to 2.3 million.<a href="https://stocktwits.com/symbol/MTVA">MTVA stock</a> gained around 7% on Thursday, while retail sentiment on Stocktwits remained in the ‘bearish’ territory over the past 24 hours.Treasure Global Inc.&nbsp;(TGL) said its 1-for-20 reverse stock split of common stock will come into effect on December 5. The company’s shares will continue trading on Nasdaq under the symbol “TGL” on a split-adjusted basis.The reverse split reduces outstanding shares from around 17 million to 848,100 and aims to help the company regain compliance with Nasdaq’s $1 minimum bid price requirement.<a href="https://stocktwits.com/symbol/TGL">TGL shares</a> were up marginally on Thursday as retail sentiment on Stocktwits remained ‘bullish’ over the past 24 hours.&nbsp;Tactical Resources Corp.’s (USREF) 5-for-1 share consolidation will come into effect on December 5. The action will reduce the total outstanding shares to around 7.35 million.<a href="https://stocktwits.com/symbol/USREF">USREF shares</a> had climbed 1% as retail sentiment on Stocktwits remained in the ‘bullish’ zone.For updates and corrections, email newsroom[at]stocktwits[dot]com.

IMG, MTVA, USREF, TGL: These Four Stocks Trade Ex-Reverse Split On Friday

A reverse split raises the stock’s price by reducing the share count, helping the company regain compliance and avoid delisting.

Equity

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$1.51
Prev Close	$1.59
Open	$1.55
Dividend Yield	0.00%
50-Day Moving Average	$4.66
Beta	1.00
Avg. Volume	285,676.60
PE Ratio	-0.10

52-Week High	$23.10
52-Week Low	$1.43
Market Capitalization	$5.01M
EPS (Annual)	-$39.13
Price to Book	0.53
Revenue Per Employee	$0.00

MTVA
MetaVia Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest MTVA News

MTVAMetaVia Inc.